Shield Therapeutics PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.02 |
Market Cap |
GBP127.04 M |
Shares Outstanding |
117.09 M |
Public Float |
19.9 M |
Address |
Northern Design Centre Gatehead Quays GH NE8 3DF United Kingdom |
Employees | - |
Website | http://shieldtherapeutics.com |
Updated | 07/08/2019 |
Shield Therapeutics Plc is a pharmaceutical company. It engages in the development and commercialization of secondary care focused pharmaceuticals. Its products include Feraccru, which treats oral problems with iron deficiency anaemia; and PT20, which treats hyperphosphatemia. |